SRTS
Sensus Healthcare Inc
NASDAQ: SRTS · HEALTHCARE · MEDICAL DEVICES
$3.02
+0.17% today
Updated 2026-07-17
Market cap
$48.73M
P/E ratio
—
P/S ratio
2.16x
EPS (TTM)
$-0.47
Dividend yield
—
52W range
$3 – $6
Volume
0.1M
WallStSmart proprietary scores
33
out of 100
Grade: F
Strong Sell
Investment rating
4.7
Growth
C8.5
Quality
A2.0
Profitability
F4.0
Valuation
C3/9
Piotroski F-Score
Weak
6.8
Altman Z-Score
Safe zone
—
Industry rank
—
View all highly rated stocks (75+) →199 stocks currently score above 75
Price targets
Analyst target
$5.75
+90.40%
12-Month target
—
—
Intrinsic (DCF)
$3.63
Margin of safety
-31.13%
1 Strong Buy3 Buy0 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Altman Z 6.84 — safe zone
+ Debt/equity 0.01x — low leverage
Risks
- Piotroski 3/9 — weak financial health
- Thin margins at -34.50%
- Negative free cash flow $-3.76M
- Revenue declining -59.30% QoQ
- 31.13% above intrinsic value
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $44.53M | $24.41M | $41.81M | $27.48M | $22.53M |
| Net income | $24.24M | $485000.00 | $6.65M | $-7.72M | $-2.63M |
| EPS | — | — | — | — | $-0.47 |
| Free cash flow | $-1.57M | $-2.37M | $-1.11M | $332000.00 | $-3.76M |
| Profit margin | 54.44% | 1.99% | 15.90% | -28.09% | -34.50% |
Peer comparison
Smart narrative
Sensus Healthcare Inc trades at $3.02. Our Smart Value Score of 33/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of 6.84, it sits in the safe zone. TTM revenue stands at $22.53M. with profit margins at -34.50%. Our DCF model estimates intrinsic value at $3.63.
Frequently asked questions
What is Sensus Healthcare Inc's stock price?
Sensus Healthcare Inc (SRTS) trades at $3.02, on a P/S of 2.2x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Sensus Healthcare Inc overvalued?
Sensus Healthcare Inc carries a Smart Value Score of 33/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read. On valuation specifically, our conservative DCF puts intrinsic value at $3.63 against the $3.02 price, so on cash flow terms the market is paying a premium for Sensus Healthcare Inc's growth. The Strong Sell rating reflects that growth and quality, while the DCF flags that the price already assumes a lot.
What is the price target of Sensus Healthcare Inc (SRTS)?
The 12-month analyst consensus target is $5.75, about 90.4% above the current $3.02. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is the intrinsic value of Sensus Healthcare Inc (SRTS)?
Our DCF model estimates intrinsic value at $3.63, a -31.1% margin of safety versus today's $3.02. Intrinsic value is what the projected cash flows are worth today. A negative reading means the price is running ahead of that conservative estimate, leaving little downside cushion if growth slows.
What is Sensus Healthcare Inc's revenue?
Sensus Healthcare Inc's trailing twelve-month revenue is $22.53M. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
Sensus Healthcare Inc's Altman Z-Score is 6.84, which places it in the safe zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryMEDICAL DEVICES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio2.16x
ROE-17.07%
Beta1.09
50D MA$3.20
200D MA$3.83
Shares out0.02B
Float0.01B
Short ratio—
Avg volume0.1M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—